www.centogene.com Open in urlscan Pro
52.57.11.73  Public Scan

Form analysis
2 forms found in the DOM

GET /search

<form class="t3m-SearchForm relative" action="/search" method="get" data-suggest="/search-api">
  <div class="autoComplete_wrapper" role="combobox" aria-owns="autoComplete_list_1" aria-haspopup="true" aria-expanded="false"><input
      class="t3m-SearchForm-textInput placeholder-t3m-muted border-t3m-border-color focus:ring-t3m-input-focus-ring-color focus:border-t3m-input-focus-ring-color tx-solr-suggest w-full pr-10 font-light rounded-md" type="text" name="tx_solr[q]"
      value="" placeholder="Enter your search term" autocomplete="off" aria-controls="autoComplete_list_1" aria-autocomplete="both">
    <ul id="autoComplete_list_1" role="listbox" hidden=""></ul>
  </div>
  <div class="absolute inset-y-0 right-0 z-10 flex items-center pr-5"><span class="input-group-btn flex"><button class="btn btn-default tx-solr-submit" type="submit"><span><svg class="text-t3m-gray w-4" xmlns="http://www.w3.org/2000/svg"
            viewBox="0 0 512 512" fill="currentColor">
            <path
              d="M508.5 468.9L387.1 347.5c-2.3-2.3-5.3-3.5-8.5-3.5h-13.2c31.5-36.5 50.6-84 50.6-136C416 93.1 322.9 0 208 0S0 93.1 0 208s93.1 208 208 208c52 0 99.5-19.1 136-50.6v13.2c0 3.2 1.3 6.2 3.5 8.5l121.4 121.4c4.7 4.7 12.3 4.7 17 0l22.6-22.6c4.7-4.7 4.7-12.3 0-17zM208 368c-88.4 0-160-71.6-160-160S119.6 48 208 48s160 71.6 160 160-71.6 160-160 160z">
            </path>
          </svg></span></button></span></div>
  <div class="t3m-SearchForm-backdrop"></div>
</form>

GET /search

<form class="t3m-SearchForm relative" action="/search" method="get" data-suggest="/search-api">
  <div class="t3m-SearchForm-textInput-wrapper focus-within:border-transparent border-b border-white">
    <div class="autoComplete_wrapper" role="combobox" aria-owns="autoComplete_list_2" aria-haspopup="true" aria-expanded="false"><input
        class="t3m-SearchForm-textInput focus:placeholder-t3m-muted focus:bg-white focus:border-transparent focus:ring-t3m-border-color focus:pl-4 focus:pr-10 tx-solr-suggest px-0 py-1 pr-10 font-light text-white placeholder-white transition-all duration-200 bg-transparent border border-transparent rounded-md"
        id="" type="text" name="tx_solr[q]" value="" placeholder="Enter your search term" autocomplete="off" aria-controls="autoComplete_list_2" aria-autocomplete="both">
      <ul id="autoComplete_list_2" role="listbox" hidden=""></ul>
    </div>
    <div class="absolute inset-y-0 right-0 flex items-center pr-3"><span class="input-group-btn flex"><button class="btn btn-default tx-solr-submit" type="submit"><span><svg class="w-4 text-white" xmlns="http://www.w3.org/2000/svg"
              viewBox="0 0 512 512" fill="currentColor">
              <path
                d="M508.5 468.9L387.1 347.5c-2.3-2.3-5.3-3.5-8.5-3.5h-13.2c31.5-36.5 50.6-84 50.6-136C416 93.1 322.9 0 208 0S0 93.1 0 208s93.1 208 208 208c52 0 99.5-19.1 136-50.6v13.2c0 3.2 1.3 6.2 3.5 8.5l121.4 121.4c4.7 4.7 12.3 4.7 17 0l22.6-22.6c4.7-4.7 4.7-12.3 0-17zM208 368c-88.4 0-160-71.6-160-160S119.6 48 208 48s160 71.6 160 160-71.6 160-160 160z">
              </path>
            </svg></span></button></span></div>
  </div>
  <div class="t3m-SearchForm-backdrop"></div>
</form>

Text Content

COOKIES SETTINGS

This website uses different types of cookies to improve your user experience.
You can change your decision at any time via the Cookie Settings. Further
information can be found in our Data Protection Policy. You can decide which
cookies you allow or reject. You can select from the following three types:



Required


Required cookies are used to enable basic website functionalities such as page
navigation, to verify if a visitor has read the cookie notification, and to save
visitor’s cookie settings. Therefore, we use our own cookies. Required cookies
cannot be disabled, otherwise our website would not function correctly.



Statistical


Statistical cookies are used to analyse and improve our website on the basis of
general usage patterns. We have external partners who use analysis methods (e.g.
cookies or fingerprints) to measure how often our site is visited and how it is
used.



Marketing


We use tracking technologies for marketing purposes, including third parties who
may use cookies, fingerprints, tracking pixels and IP addresses across devices.

In this context, we also use service providers in third countries outside the EU
without an adequate level of data protection, which entails the following risks:
Access by authorities without information, no rights of data subjects, no legal
remedies, loss of control.

With your choice of settings you consent to the processes described above. You
can revoke your consent with effect for the future at any time.



Third-party multi- and social media content

In some cases we embed content from other websites. This embedded content may be
photos or videos, but also services such as advanced comment systems and sharing
content on social networks. Embedded content can place cookies from these third
party websites, which we cannot influence. We offer content from the following
providers:
Youtube
Privacy policy Accept selected Select all
HomeCentoPortal®Investors

Centogene Logo Centogene Logo
Open menu
About Us
Why Choose CENTOGENEThe CENTOGENE BiodatabankLeadership
TeamAccreditationsInvestors
Diagnostics
Benefits of Testing with CENTOGENEOur TestsHow to OrderMultiomic SolutionsNGS
PanelsWESWGSCentoCloud®
Pharma
What We Do for PharmaClinical Trial SupportPatient Identification and
StratificationDrug Discovery and Development
Patient
What We Do For PatientsGenetic TestingPatient Advocacy
Resources
WebinarsScientific PublicationsDownloads
About Us
Why Choose CENTOGENEThe CENTOGENE BiodatabankLeadership
TeamAccreditationsInvestors
Diagnostics
Benefits of Testing with CENTOGENEOur TestsHow to OrderMultiomic SolutionsNGS
PanelsWESWGSCentoCloud®
Pharma
What We Do for PharmaClinical Trial SupportPatient Identification and
StratificationDrug Discovery and Development
Patient
What We Do For PatientsGenetic TestingPatient Advocacy
Resources
WebinarsScientific PublicationsDownloads
HomeCentoPortal®Investors



ENABLING THE CURE OF 100 RARE DISEASES IN 10 YEARS

CENTOGENE is the unique and essential partner for patients, physicians, and
biopharma, from diagnostics to discovery to clinical development to market
access & expansion in rare, metabolic, and neurodegenerative diseases.







>650,000


INDIVIDUALS IN THE CENTOGENE BIODATABANK


>361,867


COLLECTED BIOSAMPLES


16,569


ACTIVE PHYSICIANS IN OUR NETWORK


>4,522


GENES COVERED IN TESTING PORTFOLIO

WORKING TOGETHER WITH OUR PATIENTS,
PHYSICIANS, AND PARTNERS TO DIAGNOSE,
UNDERSTAND, AND TREAT RARE, METABOLIC, AND
NEURODEGENERATIVE DISEASES.



About our company




CENTOCLOUD NEWS
CENTOCLOUD – MEDICAL REPORTING


BY CHOOSING CENTOCLOUD, OUR CLINICAL DECISION SUPPORT PLATFORM, YOU NOW HAVE THE
OPTION TO ADD ON TO YOUR BIOINFORMATIC ANALYSIS WITH A PHYSICIAN-READY,
EASY-TO-INTERPRET REPORT OF DIAGNOSTIC FINDINGS FROM OUR EXPERIENCED MEDICAL
EXPERTS. DISCOVER NOW HOW YOU CAN TAKE ADVANTAGE OF CENTOGENE'S MEDICAL
REPORTING WITH CENTOCLOUD.

Meet CentoCloud

Diagnose. Understand. Treat.

DIAGNOSE.


DIAGNOSE.

To create a map, we integrate omic data from patients with the same disease to
form an atlas representing a comprehensive collection of unique and detailed
clinical and biochemical information about each rare disease.

Learn more

UNDERSTAND.


UNDERSTAND.

Understanding the details of disease pathways – faulty genes and how they affect
associated proteins, and how that leads to specific symptoms – can provide our
pharmaceutical partners with valuable clues on how best to research treatments,
by developing a drug to target specific molecules along disease pathways for
example.

Learn more

TREAT.


TREAT.

The combination of omic technologies can identify drugs and drug targets with
greater certainty, reducing the risk of failure and making drug development for
rare diseases more financially attractive to pharma. Our goal: to enable the
cure of 100 diseases in 10 years.

Learn more


TOP COMPANY NEWS

CENTOGENE TO PARTICIPATE IN UPCOMING PARTNERING CONFERENCES IN OCTOBER

Company management and the business development team will be attending events in
the U.K. and Germany. CENTOGENE invites partners to schedule…

6 Oct, 2022 Read more

CENTOGENE REACHES 12,500 PATIENT MILESTONE IN WORLD’S LARGEST OBSERVATIONAL
STUDY ON PARKINSON’S DISEASE GENETICS

Working together with Denali Therapeutics to accelerate data-driven precision
medicine for the PD community



3 Oct, 2022 Read more

CENTOGENE TO PRESENT AT UPCOMING INVESTOR & PARTNERING CONFERENCES IN SEPTEMBER

Centogene N.V. (Nasdaq: CNTG), the commercial-stage essential biodata life
science partner for rare and neurodegenerative diseases, today announced…

1 Sep, 2022 Read more


VISIT OUR ONLINE ORDERING PORTAL

CENTOPORTAL® IS A USER-FRIENDLY, ONLINE, WEB-BASED ORDERING PORTAL DESIGNED TO
ASSIST YOU AT EVERY STEP OF PROCESSING YOUR PATIENTS' SAMPLES.

Go to CentoPortal




FOOTER

For all the latest news in clinical diagnostics and rare disease …
Sign up to our newsletter

GET IN TOUCH

 * Careers
 * Contact Us

NEWS & EVENTS

 * News
 * Conferences & Events
 * Rare Disease Day 2022

KEY DISEASES

 * Gaucher Disease
 * Niemann-Pick Type C
 * Parkinson's Disease

INVESTORS

 * Investor Website
 * News & Events
 * Stock Information
 * Governance
 * General Meeting
 * Financials
 * Resources

LEGAL

 * Imprint
 * Data Protection Policy
 * HIPAA Privacy
 * Terms of Use
 * Terms and Conditions
 * Cookie Settings
 * Whistleblower Hotline
 * General Purchasing Terms

FOLLOW US

Facebook Twitter LinkedIn YouTube
© 2022 CENTOGENE N.V.